Events Archives - Page 68 of 128

2 minute read

Allogene Therapeutics Announces Encore Presentation Of Phase 1 Data From The ALLO-501/501A Trials In Large B Cell Lymphoma At The European Hematology Association Hybrid Congress

May 11, 11:51 AM

Data Will Also Be Presented in a Poster Session at the American Society of Clinical Oncology (ASCO) Annual Meeting on June 3, 2023 SOUTH SAN FRANCISCO, Calif., May 11, 2023 (GLOBE NEWSWIRE) -- Allogene Therapeutics,

ALLO

1 minute read

Actinium Pharma Announces Iomab-B SIERRA Trial Results Accepted For Oral Presentation At The European Hematology Association 2023 Congress

By Happy Mohamed

May 11, 11:20 AM

Actinium Pharmaceuticals, Inc. (NYSE:ATNM) (Actinium or the Company), a leader in the development of targeted radiotherapies, today announced that an abstract has been accepted for oral presentation at the upcoming

ATNM

3 minute read

Editas Medicine To Present Clinical Data From The RUBY Trial Of EDIT-301 For The Treatment Of Severe Sickle Cell Disease At The EHA 2023 Congress

By Happy Mohamed

May 11, 10:33 AM

Editas Medicine, Inc. (NASDAQ:EDIT), a clinical stage genome editing company, today announced that a scientific abstract detailing safety and efficacy clinical data from the Phase 1/2 RUBY trial of EDIT-301 in

EDIT

2 minute read

Cellectis Announces Poster Presentation On BALLI-01 At The European Hematology Association 2023

By Happy Mohamed

May 11, 10:23 AM

Cellectis (the "Company") (NASDAQ:CLLS), a clinical-stage biotechnology company using its pioneering gene-editing platform to develop life-saving cell and gene therapies, today announced the release of an

CLLS

1 minute read

Disc Medicine Announces Presentation Of Initial Data From Phase 2 BEACON Trial In Patients With Erythropoietic Protoporphyria At European Hematology Association 2023 Congress

By Happy Mohamed

May 11, 10:16 AM

Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases,

IRON

1 minute read

Google Maps Unveils Immersive View For Routes: Take A Virtual Trip Before Hitting the Road

By Ananya Gairola

May 11, 7:25 AM

Alphabet Inc.’s (NASDAQ:GOOGL) Google Maps has introduced a new feature called Immersive View for routes that allow users to preview their entire journey…

GOOG

2 minute read

Google’s Swipe At Apple Over Texting Standards Draws Chuckles, Claps At I/O 2023

By Ananya Gairola

May 11, 7:09 AM

During Alphabet Inc.’s (NASDAQ:AAPL) when discussing texting issues between iPhone and Android users. What Happened: At the Google I/O event, Sameer Samat, an executive at the…

AAPL

4 minute read

Events
News

“Leaker Claims Apple Used ‘Multi-Step Sting’ Operation To Identify And Fire Their Source Ahead Of WWDC” – 9To5Mac

By Happy Mohamed

May 10, 12:28 PM

https://9to5mac.com/2023/05/10/apple-leaker-sting-operation-source-fired/

AAPL

4 minute read

Ardelyx Presents Data At DDW 2023 On IBSRELA, A First-In-Class Treatment For IBS-C In Adults

By Happy Mohamed

May 9, 8:25 AM

IBSRELA provides meaningful reduction of multiple abdominal symptoms Patient-reported outcomes are strongly correlated with IBS-C abdominal symptom score WALTHAM, Mass., May 09, 2023 (GLOBE NEWSWIRE) -- Ardelyx,

ARDX

2 minute read

Celcuity To Present Updated Results For Treatment-Naïve Patients From Phase 1b Study Of Gedatolisib At The 2023 ESMO Breast Cancer Annual Congress

By Happy Mohamed

May 8, 8:06 AM

Celcuity Inc. (NASDAQ:CELC), a clinical-stage biotechnology company focused on development of targeted therapies for oncology, today announced publication of an abstract reporting updated results for treatment-naïve

CELC